跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
麦甘乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Margetuximab Injection
Approved
生物制品
Margetuximab Injection
MACROGENICS, INC.
🇨🇳 National Medical Products Administration
Approval Date
Aug 29, 2023
Approval ID
8TEM1csj8JU
Company
MACROGENICS, INC.
Type
生物制品
Approval Details
Approval Id
8TEM1csj8JU
Approval Number
国药准字SJ20230009
Generic Name
马吉妥昔单抗注射液
Generic Name En
Margetuximab Injection
Trade Name
麦甘乐
Drug Type
生物制品
Dosage Form
注射剂
Strength
250mg(10ml)/瓶
Reg Date
2023-08-29
Expired Date
2028-08-28
Company Name
MACROGENICS, INC.
Company Address
9704 Medical Center Dr, Rockville, MD 20850 United States of America
Production Company Name
baxter pharmaceutical solutions,llc
Production Company Address
927 South Curry Pike,Bloomington, IN 47403 United States of America
Company Detail Path
/organization/macrogenics-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 29, 2023
Approval ID
8TEM1csj8JU
Type
生物制品
Back to NMPA Approvals